LSD analogue with potential for treating schizophrenia developed

LSD analogue with potential for treating schizophrenia developed

Researchers have developed a new, neuroplasticity-promoting drug closely related to LSD that harnesses the psychedelic's therapeutic power with reduced hallucinogenic potential.

A New Form of LSD to Treat Schizophrenia

Researchers have modified LSD to treat schizophrenia without hallucinogenic effects.

Schizophrenia still suffers from many prejudices which delay the diagnosis. However, thanks to the management of the first symptoms, the evolution towards the disease can be avoided. On the occasion of the week of schizophrenia, we take stock with Mylène Moyal, psychiatrist at the GHU (hospitalo-university group) Paris psychiatry and neurosciences, on the causes and the management of this psychiatric pathology which concern some 600,000 people i…

Psychedelics: Experts Call for More Medical Education

It’s time to close the gap between patient interest in psychedelic therapies and clinical education, researchers say. Medscape Medical News

Educating Patients About Cobenfy for the Treatment of Schizophrenia

Here's what patients should know about Cobenfy for the treatment of schizophrenia.